HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. Ownership & Insider Activity

HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. (HEPA) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 37.7% of shares outstanding. Institutional investors hold 0.0%. Over the past 90 days, insiders made 6 purchases worth $835K.

Shares Outstanding

90.219M

Shares Float

78.699M

Insider Shares Owned

10.973M

Insider % Owned

37.7%

Institutional Shares Held

704.000

Institutional % Held

0.0%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

$835K total

Sales (90d)

Net Activity

Net Buying

Net Value (90d)

$835K

HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. Insider Transactions (Last 6 Months)

See all insider trades →

Date	Insider	Title	Type	Shares	Price	Value
Sep 29, 2026	Danina Fisher	DIRECTOR	BUY	200.000K	$0.05	$10K
Aug 3, 2026	Gary Stetz II	DIRECTOR	BUY	500.000K	$0.05	$25K
Aug 3, 2026	Gary S Stetz	INTERIM CEO	BUY	2.000M	$0.05	$100K
Aug 3, 2026	Michael Purcell	DIRECTOR	BUY	2.000M	$0.05	$100K
Aug 3, 2026	Sireesh Appajosyula	CHIEF OPERATING OFFICER	BUY	2.000M	$0.05	$100K
Aug 3, 2026	Vincent S LoPriore	EXECUTIVE CHAIRMAN	BUY	10.000M	$0.05	$500K
Apr 21, 2026	Michael Purcell	DIRECTOR	BUY	1.250M	$0.04	$50K
Apr 21, 2026	Vincent S LoPriore	EXECUTIVE CHAIRMAN	BUY	6.250M	$0.04	$250K
Apr 21, 2026	Sireesh Appajosyula	DIRECTOR	BUY	1.250M	$0.04	$50K
Apr 21, 2026	Gary S Stetz	INTERIM CEO	BUY	1.250M	$0.04	$50K

More with Benzinga EdgeGet Access